|
EXOSC3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.200200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.624500E-02 |
| Normal-vs-Stage2 |
3.279000E-01 |
| Normal-vs-Stage3 |
6.000200E-01 |
| Normal-vs-Stage4 |
2.210800E-01 |
| Stage1-vs-Stage2 |
7.150000E-01 |
| Stage1-vs-Stage3 |
7.495700E-03 |
| Stage1-vs-Stage4 |
7.289400E-01 |
| Stage2-vs-Stage3 |
1.704000E-01 |
| Stage2-vs-Stage4 |
6.226200E-01 |
| Stage3-vs-Stage4 |
1.399350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.282200E-01 |
| Normal-vs-AfricanAmerican |
1.910170E-02 |
| Normal-vs-Asian |
2.738000E-01 |
| Caucasian-vs-AfricanAmerican |
1.361750E-01 |
| Caucasian-vs-Asian |
6.843200E-01 |
| AfricanAmerican-vs-Asian |
8.391600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.329600E-01 |
| Normal-vs-Female |
8.820700E-04 |
| Male-vs-Female |
8.804200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.760600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.520200E-02 |
| Normal-vs-Age(61-80Yrs) |
3.444200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.096400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.713800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.250600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.598590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.103600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.566990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.288000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.168500E-04 |
| Normal-vs-Grade 2 |
6.860500E-03 |
| Normal-vs-Grade 3 |
8.248400E-01 |
| Normal-vs-Grade 4 |
5.691400E-01 |
| Grade 1-vs-Grade 2 |
7.421600E-02 |
| Grade 1-vs-Grade 3 |
2.995800E-03 |
| Grade 1-vs-Grade 4 |
7.217500E-02 |
| Grade 2-vs-Grade 3 |
6.848100E-04 |
| Grade 2-vs-Grade 4 |
5.960000E-01 |
| Grade 3-vs-Grade 4 |
5.017400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.299400E-03 |
| Normal-vs-ccB subtype |
4.511200E-01 |
| ccA subtype-vs-ccB subtype |
6.370700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.921820E-01 |
| Normal-vs-N1 |
6.254800E-01 |
| N0-vs-N1 |
9.707000E-01 |
|
|
